Bertolino Arthur Peter
Insider CIK 1426344 · CTIX President and CMO, Director · RVNC EVP and Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IPIX Innovation Pharmaceuticals | F Tax w/h | 2019-09-01 | 2019-09-06 | 421,611 | $0.13 | $54.8K | 2,059,316 | SEC↗ |
| IPIX Innovation Pharmaceuticals | F Tax w/h | 2018-10-12 | 2018-10-15 | 218,946 | $0.40 | $87.6K | 2,480,927 | SEC↗ |
| IPIX Innovation Pharmaceuticals | A Award deriv | 2018-09-01 | 2018-09-24 | 617,839 | — | $0 | 617,839 | SEC↗ |
| IPIX Innovation Pharmaceuticals | A Award | 2018-09-01 | 2018-09-24 | 1,066,667 | — | $0 | 2,699,873 | SEC↗ |
| IPIX Innovation Pharmaceuticals | F Tax w/h | 2017-12-22 | 2017-12-27 | 238,048 | $0.70 | $166.6K | 1,633,206 | SEC↗ |
| IPIX Innovation Pharmaceuticals | A Award deriv | 2017-09-01 | 2017-09-06 | 617,839 | — | $0 | 617,839 | SEC↗ |
| IPIX Innovation Pharmaceuticals | A Award | 2017-09-01 | 2017-09-06 | 1,066,667 | — | $0 | 1,871,254 | SEC↗ |
| CTIX Cellceutix CORP | A Award deriv | 2016-06-30 | 2016-07-07 | 617,839 | — | $0 | 617,839 | SEC↗ |
| CTIX Cellceutix CORP | A Award | 2016-06-30 | 2016-07-07 | 1,066,667 | — | $0 | 1,066,667 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-11-17 | 2015-11-17 | 2,277 | $39.11 | $89.1K | 34,016 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-11-17 | 2015-11-17 | 15 | $39.55 | $593 | 34,001 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-11-17 | 2015-11-17 | 36 | $39.55 | $1.4K | 36,293 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-11-17 | 2015-11-17 | 5,425 | $39.11 | $212.2K | 36,329 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2015-09-02 | 2015-09-04 | 3,699 | $30.48 | $112.7K | 41,754 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-01-28 | 2015-01-30 | 34,445 | — | $0 | 34,445 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-01-28 | 2015-01-30 | 6,078 | — | $0 | 45,453 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-09-02 | 2014-09-02 | 118,125 | — | $0 | 118,125 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2014-09-02 | 2014-09-02 | 39,375 | — | $0 | 39,375 | SEC↗ |